Oncolytics Biotech Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	14.63	15.94	34.91	11.67	41.26	31.22
Short-Term Investments	-	-	-	20.47	-	-
Cash & Short-Term Investments	14.63	15.94	34.91	32.14	41.26	31.22
Cash Growth	-41.14%	-54.34%	8.63%	-22.11%	32.17%	120.66%
Other Receivables	0.07	0.07	0.02	0.03	0.08	0.09
Receivables	0.07	0.07	0.02	0.03	0.08	0.09
Prepaid Expenses	3.17	1.89	3.25	1.7	2.78	2.43
Other Current Assets	1.02	0.98	-	1.82	0.78	-
Total Current Assets	18.9	18.88	38.17	35.68	44.9	33.74
Property, Plant & Equipment	1.08	1.31	0.65	0.65	0.98	0.61
Other Long-Term Assets	-	-	-	1	-	-
Total Assets	19.97	20.19	38.82	37.33	45.88	34.35
Accounts Payable	1.33	1.09	1.08	2.25	0.59	1.81
Accrued Expenses	3.95	3.71	2.49	1.4	1.39	-
Current Portion of Leases	0.29	0.28	0.13	0.22	0.29	0.25
Other Current Liabilities	0.98	1.62	0.53	0.08	0.41	0.66
Total Current Liabilities	6.56	6.69	4.24	3.95	2.69	2.71
Long-Term Leases	0.6	0.79	0.29	0.16	0.36	0.15
Long-Term Unearned Revenue	6.73	6.73	6.73	6.73	6.73	6.73
Total Liabilities	13.89	14.2	11.26	10.83	9.78	9.59
Common Stock	451.14	438.19	430.91	404.04	391.35	356.82
Additional Paid-In Capital	44.79	44.54	42.12	40.05	34.16	31.02
Retained Earnings	-490.57	-477.71	-446	-418.25	-393.42	-367.11
Comprehensive Income & Other	0.72	0.96	0.54	0.66	4.01	4.02
Shareholders' Equity	6.09	5.98	27.56	26.5	36.1	24.75
Total Liabilities & Equity	19.97	20.19	38.82	37.33	45.88	34.35
Total Debt	0.89	1.06	0.42	0.37	0.66	0.4
Net Cash (Debt)	13.74	14.88	34.49	31.77	40.61	30.82
Net Cash Growth	-42.12%	-56.86%	8.58%	-21.77%	31.77%	125.91%
Net Cash Per Share	0.17	0.19	0.51	0.55	0.76	0.76
Filing Date Shares Outstanding	100.36	86.42	75.42	62.83	57.11	52.08
Total Common Shares Outstanding	97.41	80.02	74.42	61.33	55.04	46.17
Working Capital	12.34	12.19	33.94	31.74	42.21	31.03
Book Value Per Share	0.06	0.07	0.37	0.43	0.66	0.54
Tangible Book Value	6.09	5.98	27.56	26.5	36.1	24.75
Tangible Book Value Per Share	0.06	0.07	0.37	0.43	0.66	0.54
Machinery	-	0.86	0.75	0.74	0.69	0.78
Leasehold Improvements	-	0.18	0.23	0.23	0.23	0.5

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.